Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
/afaqs/media/media_files/2026/03/12/glp-2026-03-12-15-21-38.jpg)
India warns pharma firms against ads for weight-loss drugs
India's drug regulator has warned pharmaceutical companies against directly or indirectly advertising prescription weight-loss medicines, including GLP-1 drugs used to treat obesity and diabetes. In an advisory issued by the Central Drugs Standard…
Centerview's Tokat Sees Potential for Mega Pharma Deals in 2026
A more permissive regulatory environment and Big Pharma's need to replenish revenue pipelines could spur the first $20 billion-plus M&A drug deal in more than three years, according to Centerview Partners Co-President Eric Tokat. “If there…
EU-approved sterile pharma facility launched
The launch of Sri Lanka's first locally manufactured self-dialysis solution bags by Kelun Lifesciences has coincided with the World Kidney Day. The company said the new supply bags, designed for home-based self-dialysis treatment, would benefit…
Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
HERZLIYA, Israel and CALGARY, AB, March 11, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the 'Company' or 'Innocan') is pleased to announce that it intends to complete an offering of a debenture of the Company (the…
Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPF) Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDT Adam Steensberg - President & CEO Yihan Li - Barclays Bank PLC, Research Division Barclays Bank PLC, Research Division Hey, good afternoon…
Marco Pharma International's vision for 2045: Expanding impact without compromising principles
What does success look like in 2045 for a family-run natural medicine company that refuses to cut corners? Isaac Conyers IV thinks about that question often. The Director of Operations at Marco Pharma International carries a legacy that started the…
Obesity Drugmaker Zealand Plans New Boston Research Hub
Zealand Pharma A/S plans to open a new research facility in Boston, part of the obesity drugmaker's effort to expand its presence in the US. The Danish company will likely hire between 50 and 100 people at the new lab, Chief Executive Officer Adam…
Innate Pharma's (IPHA) Buy Rating Reaffirmed at BTIG Research
Innate Pharma (NASDAQ:IPHA - Get Free Report)'s stock had its 'buy' rating reissued by equities research analysts at BTIG Research in a note issued to investors on Thursday, Benzinga reports. They currently have a $8.00 target price on the stock.
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Time to Buy?
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) gapped up prior to trading on Thursday. The stock had previously closed at $39.79, but opened at $41.90. Zealand Pharma A/S shares last traded at $41.50, with a volume of 600 shares traded. A…
HC Wainwright Estimates Spyglass Pharma FY2025 Earnings
Spyglass Pharma, Inc. (NASDAQ:SGP - Free Report) - Stock analysts at HC Wainwright issued their FY2025 earnings per share (EPS) estimates for Spyglass Pharma in a research report issued on Tuesday, March 10th. HC Wainwright analyst Y. Chen expects…
BTIG Research Reiterates 'Buy' Rating for Ascentage Pharma Group International (NASDAQ:AAPG)
Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report)'s stock had its 'buy' rating reiterated by analysts at BTIG Research in a research note issued to investors on Thursday, Benzinga reports. They presently have a $48.00 price…
Ascendis Pharma A/S $ASND Shares Bought by Atika Capital Management LLC
Atika Capital Management LLC grew its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 35.1% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,160 shares of the…
Magnetar Financial LLC Takes Position in Royalty Pharma PLC $RPRX
Magnetar Financial LLC purchased a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional…
NewAmsterdam Pharma Company N.V. $NAMS Shares Acquired by Capital World Investors
Capital World Investors boosted its stake in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 17.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…
Russell Investments Group Ltd. Grows Position in Royalty Pharma PLC $RPRX
Russell Investments Group Ltd. grew its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 7.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional…
Receive a Daily briefing on Pharma Industry News
Get Started